CEACAM5 and colon adenocarcinoma: MFE23.CD3ζTDGA-modified lymphocytes from patient 1 demonstrated specific cytotoxic activity against the CEA-expressing gastric tumour cell line MKN45 K and the colon adenocarcinoma LS174T cell line.